Alendronate is a first-line therapy of postmenopausal women with osteoporosis in Slovenia

被引：0
|
作者：
Hren, R
Cokolic, M
机构：
[1] Univ Ljubljana, Ljubljana 1000, Slovenia
[2] Teaching Hosp Maribor, Maribor 2000, Slovenia
来源：
BONE | 2002年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
B49
引用
收藏
页码：49S / 49S
页数：1
相关论文
共 50 条
  • [21] Compliance with alendronate 10 treatment in elderly women with postmenopausal osteoporosis
    Sewerynek, Ewa
    Dabrowska, Katarzyna
    Skowronska-Jozwiak, Elibieta
    Zygmunt, Arkadiusz
    Lewinski, Andrzej
    ENDOKRYNOLOGIA POLSKA, 2009, 60 (02) : 76 - 81
  • [22] ORAL ALENDRONATE AND INTRANASAL CALCITONIN IN THE TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
    ADAMI, S
    LOMBARDI, A
    ORTOLANI, S
    PASSERI, M
    CAPIZZI, T
    JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S254 - S254
  • [23] Treatment of osteoporosis in postmenopausal women: Alendronate vs intranasal calcitonin
    Rosen, CJ
    Bonnick, SL
    Miller, PD
    Palmisano, J
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S197 - S197
  • [24] Seven years' experience with alendronate in postmenopausal Japanese women with osteoporosis
    Iwamoto, Jun
    Sato, Yoshihiro
    Uzawa, Mitsuyoshi
    Takeda, Tsuyoshi
    Matsumoto, Hideo
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2010, 6 : 201 - 206
  • [25] Focus on alendronate: A nonhormonal option for the treatment of osteoporosis in postmenopausal women
    Ashworth, L
    FORMULARY, 1996, 31 (01) : 23 - &
  • [26] Prevention and treatment of osteoporosis in postmenopausal women - Defining the role of alendronate
    Keam, SJ
    Plosker, GL
    DISEASE MANAGEMENT & HEALTH OUTCOMES, 2004, 12 (01) : 19 - 37
  • [27] Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women
    Downs, RW
    Bell, NH
    Ettinger, MP
    Walsh, BW
    Favus, MJ
    Mako, B
    Wang, LX
    Smith, ME
    Gormley, GJ
    Melton, ME
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (05): : 1783 - 1788
  • [28] Satisfaction, preference and compliance with alendronate and risedronate in postmenopausal women with osteoporosis
    Pérez, LI
    Sanidefonso, MM
    Paleo, EE
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S42 - S42
  • [29] The effectiveness of alendronate (70 mg weekly) in women with postmenopausal osteoporosis
    Martchenkova, L. A.
    Dreval, A. V.
    Kryukova, I. V.
    Tishenina, R. S.
    Milov, N. M.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S44 - S44
  • [30] 10 YEARS OF EXPERIENCE WITH ALENDRONATE IN THE TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
    Pietschmann, Peter
    JOURNAL FUR MINERALSTOFFWECHSEL, 2007, 14 (03): : 124 - 126
12345